 | • レポートコード：MRC2012A6211 • 出版社/出版日：GlobalInfoResearch / 2020年12月24日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、MSDドラッグの世界市場を広く調査・分析し、今後の市場展望をまとめております。MSDドラッグの種類別市場規模（OTC、処方薬）、用途別市場規模（病院、小売薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：AbbVie、Roche、Amgen、Johnson & Johnson、Eli Lilly、Pfizer Inc、 ・地域別グローバル市場分析 2015年-2020年 ・MSDドラッグの北米市場（アメリカ、カナダ、メキシコ） ・MSDドラッグのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・MSDドラッグのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・MSDドラッグの南米市場（ブラジル、アルゼンチン） ・MSDドラッグの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：OTC、処方薬 ・用途別分析：病院、小売薬局 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global MSD Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The MSD Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
MSD Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, MSD Drugs market has been segmented into
OTC
Rx Drugs
By Application, MSD Drugs has been segmented into:
Hospital
Retail Pharmacy
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global MSD Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level MSD Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global MSD Drugs market.
The report offers in-depth assessment of the growth and other aspects of the MSD Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and MSD Drugs Market Share Analysis
MSD Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, MSD Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the MSD Drugs sales, revenue and market share for each player covered in this report.
The major players covered in MSD Drugs are:
AbbVie
Roche
Amgen
Johnson & Johnson
Eli Lilly
Pfizer Inc
Among other players domestic and global, MSD Drugs market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe MSD Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of MSD Drugs, with price, sales, revenue and global market share of MSD Drugs in 2018 and 2019.
Chapter 3, the MSD Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the MSD Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, MSD Drugs market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe MSD Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 MSD Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global MSD Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 OTC
1.2.3 Rx Drugs
1.3 Market Analysis by Application
1.3.1 Overview: Global MSD Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.4 Overview of Global MSD Drugs Market
1.4.1 Global MSD Drugs Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 AbbVie
2.1.1 AbbVie Details
2.1.2 AbbVie Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 AbbVie SWOT Analysis
2.1.4 AbbVie Product and Services
2.1.5 AbbVie MSD Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Roche
2.2.1 Roche Details
2.2.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Roche SWOT Analysis
2.2.4 Roche Product and Services
2.2.5 Roche MSD Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Amgen
2.3.1 Amgen Details
2.3.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Amgen SWOT Analysis
2.3.4 Amgen Product and Services
2.3.5 Amgen MSD Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Johnson & Johnson
2.4.1 Johnson & Johnson Details
2.4.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Johnson & Johnson SWOT Analysis
2.4.4 Johnson & Johnson Product and Services
2.4.5 Johnson & Johnson MSD Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Eli Lilly
2.5.1 Eli Lilly Details
2.5.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Eli Lilly SWOT Analysis
2.5.4 Eli Lilly Product and Services
2.5.5 Eli Lilly MSD Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Pfizer Inc
2.6.1 Pfizer Inc Details
2.6.2 Pfizer Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Pfizer Inc SWOT Analysis
2.6.4 Pfizer Inc Product and Services
2.6.5 Pfizer Inc MSD Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global MSD Drugs Sales and Market Share by Manufacturer (2018-2019)
3.2 Global MSD Drugs Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 MSD Drugs Manufacturer Market Share in 2019
3.3.2 Top 6 MSD Drugs Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global MSD Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global MSD Drugs Sales and Market Share by Regions (2015-2020)
4.1.2 Global MSD Drugs Revenue and Market Share by Regions (2015-2020)
4.2 North America MSD Drugs Sales and Growth Rate (2015-2020)
4.3 Europe MSD Drugs Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific MSD Drugs Sales and Growth Rate (2015-2020)
4.5 South America MSD Drugs Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa MSD Drugs Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America MSD Drugs Sales, Revenue and Market Share by Country
5.1.1 North America MSD Drugs Sales and Market Share by Country (2015-2020)
5.1.2 North America MSD Drugs Revenue and Market Share by Country (2015-2020)
5.2 United States MSD Drugs Sales and Growth Rate (2015-2020)
5.3 Canada MSD Drugs Sales and Growth Rate (2015-2020)
5.4 Mexico MSD Drugs Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe MSD Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe MSD Drugs Sales and Market Share by Country (2015-2020)
6.1.2 Europe MSD Drugs Revenue and Market Share by Country (2015-2020)
6.2 Germany MSD Drugs Sales and Growth Rate (2015-2020)
6.3 UK MSD Drugs Sales and Growth Rate (2015-2020)
6.4 France MSD Drugs Sales and Growth Rate (2015-2020)
6.5 Russia MSD Drugs Sales and Growth Rate (2015-2020)
6.6 Italy MSD Drugs Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific MSD Drugs Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific MSD Drugs Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific MSD Drugs Revenue and Market Share by Regions (2015-2020)
7.2 China MSD Drugs Sales and Growth Rate (2015-2020)
7.3 Japan MSD Drugs Sales and Growth Rate (2015-2020)
7.4 Korea MSD Drugs Sales and Growth Rate (2015-2020)
7.5 India MSD Drugs Sales and Growth Rate (2015-2020)
7.6 Southeast Asia MSD Drugs Sales and Growth Rate (2015-2020)
7.7 Australia MSD Drugs Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America MSD Drugs Sales, Revenue and Market Share by Country
8.1.1 South America MSD Drugs Sales and Market Share by Country (2015-2020)
8.1.2 South America MSD Drugs Revenue and Market Share by Country (2015-2020)
8.2 Brazil MSD Drugs Sales and Growth Rate (2015-2020)
8.3 Argentina MSD Drugs Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa MSD Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa MSD Drugs Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa MSD Drugs Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia MSD Drugs Sales and Growth Rate (2015-2020)
9.3 Turkey MSD Drugs Sales and Growth Rate (2015-2020)
9.4 Egypt MSD Drugs Sales and Growth Rate (2015-2020)
9.5 South Africa MSD Drugs Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global MSD Drugs Sales and Market Share by Type (2015-2020)
10.2 Global MSD Drugs Revenue and Market Share by Type (2015-2020)
10.3 Global MSD Drugs Price by Type (2015-2020)
11 Global MSD Drugs Market Segment by Application
11.1 Global MSD Drugs Sales Market Share by Application (2015-2020)
11.2 Global MSD Drugs Revenue Market Share by Application (2015-2020)
11.3 Global MSD Drugs Price by Application (2015-2020)
12 Market Forecast
12.1 Global MSD Drugs Sales, Revenue and Growth Rate (2021-2025)
12.2 MSD Drugs Market Forecast by Regions (2021-2025)
12.2.1 North America MSD Drugs Market Forecast (2021-2025)
12.2.2 Europe MSD Drugs Market Forecast (2021-2025)
12.2.3 Asia-Pacific MSD Drugs Market Forecast (2021-2025)
12.2.4 South America MSD Drugs Market Forecast (2021-2025)
12.2.5 Middle East & Africa MSD Drugs Market Forecast (2021-2025)
12.3 MSD Drugs Market Forecast by Type (2021-2025)
12.3.1 Global MSD Drugs Sales Forecast by Type (2021-2025)
12.3.2 Global MSD Drugs Market Share Forecast by Type (2021-2025)
12.4 MSD Drugs Market Forecast by Application (2021-2025)
12.4.1 Global MSD Drugs Sales Forecast by Application (2021-2025)
12.4.2 Global MSD Drugs Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global MSD Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of MSD Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global MSD Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. AbbVie Basic Information, Manufacturing Base and Competitors
Table 8. AbbVie MSD Drugs Major Business
Table 9. AbbVie MSD Drugs Total Revenue (USD Million) (2017-2018)
Table 10. AbbVie SWOT Analysis
Table 11. AbbVie MSD Drugs Product and Services
Table 12. AbbVie MSD Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Roche Basic Information, Manufacturing Base and Competitors
Table 14. Roche MSD Drugs Major Business
Table 15. Roche MSD Drugs Total Revenue (USD Million) (2017-2018)
Table 16. Roche SWOT Analysis
Table 17. Roche MSD Drugs Product and Services
Table 18. Roche MSD Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Amgen Basic Information, Manufacturing Base and Competitors
Table 20. Amgen MSD Drugs Major Business
Table 21. Amgen MSD Drugs Total Revenue (USD Million) (2017-2018)
Table 22. Amgen SWOT Analysis
Table 23. Amgen MSD Drugs Product and Services
Table 24. Amgen MSD Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 26. Johnson & Johnson MSD Drugs Major Business
Table 27. Johnson & Johnson MSD Drugs Total Revenue (USD Million) (2017-2018)
Table 28. Johnson & Johnson SWOT Analysis
Table 29. Johnson & Johnson MSD Drugs Product and Services
Table 30. Johnson & Johnson MSD Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 32. Eli Lilly MSD Drugs Major Business
Table 33. Eli Lilly MSD Drugs Total Revenue (USD Million) (2017-2018)
Table 34. Eli Lilly SWOT Analysis
Table 35. Eli Lilly MSD Drugs Product and Services
Table 36. Eli Lilly MSD Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Pfizer Inc Basic Information, Manufacturing Base and Competitors
Table 38. Pfizer Inc MSD Drugs Major Business
Table 39. Pfizer Inc MSD Drugs Total Revenue (USD Million) (2017-2018)
Table 40. Pfizer Inc SWOT Analysis
Table 41. Pfizer Inc MSD Drugs Product and Services
Table 42. Pfizer Inc MSD Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Global MSD Drugs Sales by Manufacturer (2018-2019) (K Units)
Table 44. Global MSD Drugs Revenue by Manufacturer (2018-2019) (USD Million)
Table 45. Global MSD Drugs Sales by Regions (2015-2020) (K Units)
Table 46. Global MSD Drugs Sales Market Share by Regions (2015-2020)
Table 47. Global MSD Drugs Revenue by Regions (2015-2020) (USD Million)
Table 48. North America MSD Drugs Sales by Countries (2015-2020) (K Units)
Table 49. North America MSD Drugs Sales Market Share by Countries (2015-2020)
Table 50. North America MSD Drugs Revenue by Countries (2015-2020) (USD Million)
Table 51. North America MSD Drugs Revenue Market Share by Countries (2015-2020)
Table 52. Europe MSD Drugs Sales by Countries (2015-2020) (K Units)
Table 53. Europe MSD Drugs Sales Market Share by Countries (2015-2020)
Table 54. Europe MSD Drugs Revenue by Countries (2015-2020) (USD Million)
Table 55. Asia-Pacific MSD Drugs Sales by Regions (2015-2020) (K Units)
Table 56. Asia-Pacific MSD Drugs Sales Market Share by Regions (2015-2020)
Table 57. Asia-Pacific MSD Drugs Revenue by Regions (2015-2020) (USD Million)
Table 58. South America MSD Drugs Sales by Countries (2015-2020) (K Units)
Table 59. South America MSD Drugs Sales Market Share by Countries (2015-2020)
Table 60. South America MSD Drugs Revenue by Countries (2015-2020) (USD Million)
Table 61. South America MSD Drugs Revenue Market Share by Countries (2015-2020)
Table 62. Middle East & Africa MSD Drugs Sales by Countries (2015-2020) (K Units)
Table 63. Middle East & Africa MSD Drugs Sales Market Share by Countries (2015-2020)
Table 64. Middle East & Africa MSD Drugs Revenue by Countries (2015-2020) (USD Million)
Table 65. Middle East & Africa MSD Drugs Revenue Market Share by Countries (2015-2020)
Table 66. Global MSD Drugs Sales by Type (2015-2020) (K Units)
Table 67. Global MSD Drugs Sales Share by Type (2015-2020)
Table 68. Global MSD Drugs Revenue by Type (2015-2020) (USD Million)
Table 69. Global MSD Drugs Revenue Share by Type (2015-2020)
Table 70. Global MSD Drugs Sales by Application (2015-2020) (K Units)
Table 71. Global MSD Drugs Sales Share by Application (2015-2020)
Table 72. Global MSD Drugs Sales Forecast by Regions (2021-2025) (K Units)
Table 73. Global MSD Drugs Market Share Forecast by Regions (2021-2025)
Table 74. Global MSD Drugs Sales Forecast by Type (2021-2025) (K Units)
Table 75. Global MSD Drugs Market Share Forecast by Type (2021-2025)
Table 76. Global MSD Drugs Sales Forecast by Application (2021-2025)
Table 77. Global MSD Drugs Market Share Forecast by Application (2021-2025)
Table 78. Direct Channel Pros & Cons
Table 79. Indirect Channel Pros & Cons
Table 80. Distributors/Traders/ Dealers List
List of Figures
Figure 1. MSD Drugs Picture
Figure 2. Global Sales Market Share of MSD Drugs by Type in 2019
Figure 3. OTC Picture
Figure 4. Rx Drugs Picture
Figure 5. MSD Drugs Sales Market Share by Application in 2018
Figure 6. Hospital Picture
Figure 7. Retail Pharmacy Picture
Figure 8. Global MSD Drugs Market Status and Outlook (2015-2025) (USD Million)
Figure 9. United States MSD Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 10. Canada MSD Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Mexico MSD Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Germany MSD Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 13. France MSD Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 14. UK MSD Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Russia MSD Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Italy MSD Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 17. China MSD Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Japan MSD Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Korea MSD Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 20. India MSD Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Southeast Asia MSD Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Australia MSD Drugs Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 23. Brazil MSD Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Egypt MSD Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Saudi Arabia MSD Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 26. South Africa MSD Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Turkey MSD Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Global MSD Drugs Sales Market Share by Manufacturer in 2019
Figure 29. Global MSD Drugs Revenue Market Share by Manufacturer in 2019
Figure 30. Top 3 MSD Drugs Manufacturer (Revenue) Market Share in 2019
Figure 31. Top 6 MSD Drugs Manufacturer (Revenue) Market Share in 2019
Figure 32. Key Manufacturer Market Share Trend
Figure 33. Global MSD Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 34. Global MSD Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 35. Global MSD Drugs Revenue Market Share by Regions (2015-2020)
Figure 36. Global MSD Drugs Revenue Market Share by Regions in 2018
Figure 37. North America MSD Drugs Sales and Growth Rate (2015-2020)
Figure 38. Europe MSD Drugs Sales and Growth Rate (2015-2020)
Figure 39. Asia-Pacific MSD Drugs Sales and Growth Rate (2015-2020)
Figure 40. South America MSD Drugs Sales and Growth Rate (2015-2020)
Figure 41. Middle East & Africa MSD Drugs Sales and Growth Rate (2015-2020)
Figure 42. North America MSD Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 43. North America MSD Drugs Sales Market Share by Countries (2015-2020)
Figure 44. North America MSD Drugs Sales Market Share by Countries in 2018
Figure 45. North America MSD Drugs Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 46. North America MSD Drugs Revenue Market Share by Countries in 2018
Figure 47. United States MSD Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 48. Canada MSD Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 49. Mexico MSD Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Europe MSD Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 51. Europe MSD Drugs Revenue Market Share by Countries (2015-2020)
Figure 52. Europe MSD Drugs Revenue Market Share by Countries in 2019
Figure 53. Germany MSD Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 54. UK MSD Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 55. France MSD Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 56. Russia MSD Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Italy MSD Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Asia-Pacific MSD Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 59. Asia-Pacific MSD Drugs Sales Market Share by Regions 2019
Figure 60. Asia-Pacific MSD Drugs Revenue Market Share by Regions 2019
Figure 61. China MSD Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 62. Japan MSD Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Korea MSD Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 64. India MSD Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Southeast Asia MSD Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 66. South America MSD Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 67. South America MSD Drugs Sales Market Share by Countries in 2019
Figure 68. South America MSD Drugs Revenue Market Share by Countries in 2019
Figure 69. Brazil MSD Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 70. Argentina MSD Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Middle East and Africa MSD Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. Middle East and Africa MSD Drugs Sales Market Share by Countries in 2019
Figure 73. Middle East and Africa MSD Drugs Revenue Market Share by Countries (2015-2020)
Figure 74. Middle East and Africa MSD Drugs Revenue Market Share by Countries in 2019
Figure 75. Saudi Arabia MSD Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 76. Egypt MSD Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Turkey MSD Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 78. South Africa MSD Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Global MSD Drugs Sales and Growth Rate (2021-2025) (K Units)
Figure 80. Global MSD Drugs Revenue and Growth Rate (2021-2025) (USD Million)
Figure 81. North America Sales MSD Drugs Market Forecast (2021-2025) (K Units)
Figure 82. Europe Sales MSD Drugs Market Forecast (2021-2025) (K Units)
Figure 83. Asia-Pacific Sales MSD Drugs Market Forecast (2021-2025) (K Units)
Figure 84. South America Sales MSD Drugs Market Forecast (2021-2025) (K Units)
Figure 85. Middle East & Africa Sales MSD Drugs Market Forecast (2021-2025) (K Units)
Figure 86. Sales Channel: Direct Channel vs Indirect Channel
タイサブリ薬の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Tysabri Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Tysabri Drugs market report pro…- イロプロスト治療薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Iloprost Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade …
- 泌尿生殖器治療薬の世界市場（～2026年） A medical science concerned with the study and treatment of diseases of the genital and urinary organs, especially sexually transmitted diseases. The growing prevalence of genitourinary disorders is presumed to be the high rendering impact driver of this vertical. In addition, increasing number of p…
- バーター症候群治療薬の世界市場（～2026年） Bartter syndrome is a rare genetic disorder that causes specific defects in kidney function. Market Analysis and Insights: Global Bartter Syndrome Drugs Market The global Bartter Syndrome Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% d…
- 鼻血治療薬の世界市場（～2026年） A epistaxis, also known as nosebleed, is the common occurrence of bleeding from the nose. It is usually noticed when blood drains out through the nostrils. Epistaxis continues to remain a common health problem observed among the adults and children. Impact of extreme weather conditions can lead to c…